Tag: vaccine production in Africa

Several public and private stakeholders in our healthcare sector were shocked to learn of Moderna’s decision to abandon its plans to establish a vaccine production facility in Kenya last month, raising repeated concerns about vaccine accessibility and production capacity in Africa. “The indignation and frustration that many felt at reading these headlines places us among the thousands who, like most Africans, view Moderna’s decision as confusing and, once again, part of the trend of relegating Africans’ health and wellbeing to the whims of corporate interests,” shares Michael Mynhardt, CEO at MMH & Partners Africa. He adds that prior to the COVID-19 pandemic, people living in Africa were aware that the continent was partly, and in some cases wholly reliant on external actors for its ...